CorrespondenceParicalcitol for reduction of albuminuria in diabetes
Cited by (7)
Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells
2016, Bioconjugate ChemistryEffect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease
2015, Journal of Diabetes and its ComplicationsCitation Excerpt :The lack of statistical significance may also be due to the fact the subjects were in the late stage of disease. Nevertheless, there are other reports of microalbuminuria reduction with this drug in patients with less severe kidney disease (Ortiz et al., 2011). Another limitation of the study is that it is not known if the dose of paricalcitol used was sufficient.
Anorexia nervosa and the kidney
2012, American Journal of Kidney DiseasesCitation Excerpt :However, in patients with AN, urinary creatinine excretion might be very low compared with patients without AN. In theory, this low value could result in abnormally high levels of normalized proteinuria, and notably, the overall validity of spot protein-creatinine ratios have not been assessed in the context of AN.46 Using creatinine-based equations to estimate GFR may be misleading in many patients with AN.
Therapeutic approaches to diabetic nephropathy - beyond the RAS
2014, Nature Reviews Nephrology